Package 71610-405-60

{"route": ["ORAL"], "spl_id": "335e56e6-a09f-488d-84dc-06f0b50950df", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["897640"], "spl_set_id": ["2712ab16-122b-4f44-a687-e2cb3c04019e"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET in 1 BOTTLE (71610-405-60)", "package_ndc": "71610-405-60", "marketing_start_date": "20200318"}, {"sample": false, "description": "180 TABLET in 1 BOTTLE (71610-405-80)", "package_ndc": "71610-405-80", "marketing_start_date": "20200318"}], "brand_name": "VERAPAMIL HYDROCHLORIDE", "product_id": "71610-405_335e56e6-a09f-488d-84dc-06f0b50950df", "dosage_form": "TABLET", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "71610-405", "generic_name": "VERAPAMIL HYDROCHLORIDE", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VERAPAMIL HYDROCHLORIDE", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "180 mg/1"}], "application_number": "ANDA206173", "marketing_category": "ANDA", "marketing_start_date": "20190515", "listing_expiration_date": "20261231"}